McAdam LLC’s Celgene Corp CELG Stock Holding History

McAdam LLC’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-6,937	Closed	-$689K	–	91
2019 Q3	$689K	Buy	6,937 +320	+5%	+$30.4K	0.19%	40
2019 Q2	$612K	Hold	6,617	–	–	0.18%	43
2019 Q1	$624K	Hold	6,617	–	–	0.21%	40
2018 Q4	$424K	Hold	6,617	–	–	0.17%	44
2018 Q3	$608K	Sell	6,617 -12	-0.2%	-$1.06K	0.22%	36
2018 Q2	$526K	Buy	6,629 +12	+0.2%	+$996	0.21%	37
2018 Q1	$590K	Buy	+6,617	New	+$635K	0.27%	33

Other funds holding CELG

HCM

Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

McAdam LLC's CELG Position: Q4 2019 in Review

McAdam LLC sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,937 shares — an estimated $689K sold.

McAdam LLC first reported a position in CELG in Q1 2018 and held it in 7 quarters. The position peaked at $689K in Q3 2019. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

McAdam LLC reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
McAdam LLC sold 6,937 Celgene Corp shares in Q4 2019, an estimated $689K.
McAdam LLC first reported a position in Celgene Corp in Q1 2018 and held it in 7 quarters.
McAdam LLC's Celgene Corp position peaked at $689K in Q3 2019.
3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on McAdam LLC's 13F filing for Q4 2019, filed 23 Jan 2020.